International Paper posted a weak earnings reaction on July 30 but walked away with a wave of analyst upgrades — the tension between a falling stock and rising price targets is the defining feature of this week's setup.
The print itself landed badly. IP fell 4.2% on July 30, closing the week at $40.83, down 3.2% from seven days prior and sharply lower than the $42.16 level flagged in last week's earnings preview note. That erases the bulk of the pre-earnings rally. The prior Q1 print in May also disappointed, with a -0.5% day-one move followed by a 8% five-day decline, so the market's reflex to sell IP into results is becoming a pattern worth watching.
The Street's response, however, ran in the opposite direction. Analysts lifted targets across the board — six separate raises on July 31 alone. Deutsche Bank upgraded from Hold to Buy, lifting its target from $39 to $50. JP Morgan, which had already upgraded to Overweight on July 28, raised its target further to $61. RBC Capital pushed to $52, Citigroup to $48, and Truist to $49. The consensus now implies roughly 16% upside from current levels, and the analyst recommendation factor score ranks in the 94th percentile of the ORTEX universe — near the very top. Bulls are pointing to EPS momentum that ranks in the 85th percentile on a 30-day basis and 83rd on 90-day, suggesting forward estimates have been moving sharply higher. Bears, by contrast, appear to be fading the structural story — IP's EV/EBIT factor scores in the 12th percentile, flagging stretched enterprise valuations even as earnings recover.
Short interest has actually eased since last week's elevated reading, which is a material change from the pre-earnings setup. The position has dropped from roughly 54.7 million shares to 51.8 million — a 5.3% reduction over the week, bringing short interest to 9.8% of the free float. That's still a meaningful short position, but the direction has shifted: bears covered into the print rather than held through it. The borrow market remains loose, with availability at 766% — nearly eight shares available for every one on loan — and the cost to borrow is just 0.54%, up 18% on the week but still firmly in "low" territory. There is no mechanical squeeze pressure here. The ORTEX short score has drifted to 59, down from 60 a week ago, consistent with a modestly elevated but not extreme short setup.
Options positioning has flipped sharply from defensive to bullish. The put/call ratio has collapsed to 1.27, nearly two standard deviations below its 20-day average of 1.71 — the lowest reading in weeks and close to the 52-week low of 0.40. Where options traders were loading puts into the July 20 peak (when the PCR hit its 52-week high of 2.20), they are now rotating toward calls. That's a meaningful reversal of the pre-earnings hedging posture described in the prior note.
Capital Research remains the dominant institutional holder at 21.9% of shares, a position that grew by 13.5 million shares in the most recent reporting period. T. Rowe Price holds a further 9.8%. That degree of concentrated institutional ownership means the stock's reaction to earnings and analyst revisions tends to be amplified — large holders moving even fractionally can drive outsized price swings.
The next earnings event is scheduled for October 28. Between now and then, the key watch is whether the analyst target-lifting cycle translates into buying that closes the gap to the new consensus, or whether the market continues to sell the news as it has done twice in a row — the current reading has the stock trading roughly $7 below the mean target of $47.45, with bulls and bears both, unusually, rebuilding their cases from the same print.
See the live data behind this article on ORTEX.
Open IP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
